Ginkgo/Soaring Eagle Acquisition combine ops

摘要

US synthetic biology business Ginkgo Bioworks (Boston, Massachusetts) has combined its operations with US special purpose acquisition company Soaring Eagle Acquisition Corp (New York City, New York). The combined entity, Ginkgo Bioworks Holdings, has been listed on the US New York Stock Exchange (NYSE). The new company is valued at $15 billion, with the transaction fetching it $1.6 billion.